Search Results - "Lupichuk, S"

Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment by Shafey, M, Lupichuk, S M, Do, T, Owen, C, Stewart, D A

“…The purpose of this study was to elicit relative preferences for common treatment options of relapsed follicular lymphoma, and their associated attributes,…”
Get full text

Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age by Lupichuk, S, Tilley, D, Kostaras, X, Joy, A A

“…We compared the efficacy, toxicity, and use of granulocyte colony-stimulating factor (g-csf) with tac (docetaxel-doxorubicin-cyclophosphamide) and fec-d…”
Get full text

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid by Lazier, J, Lupichuk, S M, Sosova, I, Khan, A A

“…Hyperammonemic encephalopathy (he) is a rare complication of malignancy and chemotherapy. Although the cause of he is unclear, a functional arginine deficiency…”
Get full text

P096 Comparison of adjuvant TAC vs. FEC-D in women <50 with node positive, HER2 negative breast cancer by Lester, R.E, Tilley, D, Kostaras, X, Henning, J.W, Joy, A, Lupichuk, S

Get full text

313 A Pooled Analysis to Evaluate the Incidence of Proteinuria, Hypoalbuminemia, and Edema Secondary to MET and VEGFR Inhibition by Bradbury, P, Eisenhauer, E, Rayson, D, Lupichuk, S, Chia, S, Leighl, N, Ho, C, Seymour, L

Get full text

Optimal use of taxanes in metastatic breast cancer by King, K M, Lupichuk, S, Baig, L, Webster, M, Basi, S, Whyte, D, Rix, S

“…The role of taxanes in the treatment of breast cancer is becoming increasingly important. In clinical practice, the taxanes are now standard therapy in both…”
Get full text

1516P Real world implementation of Serious Illness Care Program (SICP) in cancer care by Karim, S., Lupichuk, S., Tan, A., Sinnarajah, A., Simon, J.

Get full text

Abstract P2-08-13: Survival in women with de novo metastatic breast cancer: Comparison of real-world evidence from publicly-funded Canadian province and the United States by insurance status by Kornaga, EN, Matutino, AR, Pereira, AA, Verma, S, Lupichuk, S

“…Abstract Background: Access to cancer screening, diagnosis and treatment in the United States (US) is affected by insurance status; whereas, access within a…”
Get full text

Adjuvant Breast Radiotherapy Alone (Without Endocrine Therapy) in Women 70 Years or Older with Early-Stage Breast Cancer Post-Breast Conservation Surgery: A Population-Based Long-Term Follow-Up Study by Wang, M., Zebak, S., Au, C., Mah, K., Alba, V., Ghosh, S., Liu, H., Wiebe, E., Chafe, S.M.J.M.J., Chambers, C., Lupichuk, S., King, K., Joseph, K.J.

Get full text

Abstract P5-20-12: Adjuvant DCH vs TCH for low-risk (node negative); and FECDH vs TCH for high-risk (node positive) HER2+ breast cancer – A retrospective provincial analysis by Veitch, ZW, Khan, OF, Tilley, D, Kostaras, X, Tang, PA, King, K, Lupichuk, S

“…Abstract Background: Chemotherapy plus trastuzumab for early HER2+ breast cancer (BC) is associated with improved survival. Optimal regimens for low-risk (node…”
Get full text

Abstract P3-12-11: Disparities in adjuvant hormone adherence in breast cancer patients within a universal healthcare model by Veitch, ZW, Khan, OF, Tilley, D, Kostaras, X, King, K, Lupichuk, S, Tang, P

“…Abstract Background: Patient adherence to adjuvant hormonal therapy for breast cancer (BC) is correlated with improved survival. Recent publications have…”
Get full text

Abstract P6-17-29: Withdrawn by Veitch, ZW, Bedard, P, Tang, PA, Conway, JL, Ribnikar, D, Albaba, H, King, K, Lupichuk, S, Cescon, D

“…Abstract This abstract was withdrawn by the authors. Citation Format: Veitch ZW, Bedard P, Tang PA, Conway JL, Ribnikar D, Albaba H, King K, Lupichuk S, Cescon…”
Get full text

Preference Of Patients And Physicians Concerning Treatment Options For Relapsed Follicular Lymphoma: A Discrete Choice Experiment by Shafey, M, Stewart, D.A, Do, T, Lupichuk, S

Get full text

Abstract P1-13-02: Real world outcomes of adjuvant FECD, ddACT and ACT for the treatment of early stage breast cancer - A multicenter retrospective analysis by LeVasseur, N, Veitch, Z, Diocee, RM, Gondara, L, Cheung, W, Khan, O, Cossetti, R, Gelmon, KA, King, K, Lupichuk, S, Chia, SK, Tang, P, Simmons, C

“…Abstract Background: Adjuvant chemotherapy combining anthracyclines and taxanes for early stage breast cancer (ESBC) have demonstrated disease-free survival…”
Get full text

The effects of losartan and captopril on vasopressor actions of cirazoline in the absence and presence of SZL-49 and nifedipine by Tabrizchi, R, Lupichuk, S M

“…The effects of the nonpeptide angiotensin II receptor antagonist losartan and the angiotensin-converting enzyme inhibitor captopril on pressor responses to the…”
Get more information

Vasodilatation produced by adenosine in isolated rat perfused mesenteric artery: a role for endothelium by Tabrizchi, R, Lupichuk, S M

“…Adenosine and adenosine triphosphate (ATP) induced vasodilatation was studied in isolated rat perfused mesenteric artery at constant flow. Decrease in…”
Get full text

Retrospective assessment of adherence to ASCO Surveillance Guidelines following treatment for stage II and III colorectal cancer (CRC) by Davies, J. M., Lupichuk, S., Batuyong, E., Hilsden, R. J., Easaw, J.

“…Abstract only e17517 Background: The 2005 ASCO guidelines for surveillance following adjuvant therapy for CRC outlined recommended surveillance tests and their…”
Get full text

Abstract P4-13-06: Real-world experience using exemestane and everolimus in patients with hormone receptor positive/HER2 negative breast cancer with and without prior CDK4/6 inhibitor exposure by Lupichuk, SM, Recaldin, B, Nixon, NA, Mututino, A, Joy, AA

“…Abstract Background: For patients with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer who progress on a non-steroidal aromatase…”
Get full text

Consequences of modifying an adjuvant treatment protocol for resected gastric carcinoma: A retrospective study at a single institution in western Canada by Bebb, D. G., Ziouzina, O., Lupichuk, S., Stefaniuk, M., Dowden, S., Chan, A., Walley, B., Chan, S., Wong, A., Doll, C.

“…Abstract only 15176 Background: Gastric adenocarcinoma has a poor outcome: surgical resection alone in stage IA-IVA is curative in < 30%. Adjuvant…”
Get full text

Preference for breast cancer risk reduction hormonal therapy in women age 50-69 years attending screening mammography by Lupichuk, SM, Currie, GR, Bryant, HE

“…Abstract Abstract #3100 Background: It is expected that tamoxifen, raloxifene and aromatase inhibitors (AIs) will become available for the indication of breast…”
Get full text